Literature DB >> 15821215

Stable patients receiving prolonged mechanical ventilation have a high alveolar burden of bacteria.

Daniel Baram1, Geoffrey Hulse, Lucy B Palmer.   

Abstract

INTRODUCTION: In patients receiving prolonged mechanical ventilation (PMV), quantitative bronchoscopic culture has not been validated for the diagnosis of ventilator-associated pneumonia (VAP).
OBJECTIVE: To measure the alveolar burden of bacteria in patients receiving PMV.
SETTING: Respiratory care units of a university hospital and a long-term care facility. PATIENTS: Fourteen patients requiring PMV without clinical evidence of pneumonia. MEASUREMENTS: Quantitative culture of BAL from the right middle lobe and lingula.
RESULTS: In 29 of 32 lobes, there was growth of at least one organism at > 10(4) cfu/mL. Most lobes had polymicrobial growth.
CONCLUSIONS: Stable patients receiving PMV without clinical pneumonia have a high alveolar burden of bacteria. The bacterial burden in most patients exceeds the commonly accepted threshold for diagnosing VAP. The utility of quantitative bronchoscopic culture in the diagnosis of VAP in this patient population requires further study.

Entities:  

Mesh:

Year:  2005        PMID: 15821215     DOI: 10.1378/chest.127.4.1353

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  Duration of antibiotic therapy in the intensive care unit.

Authors:  Gabor Zilahi; Mary Aisling McMahon; Pedro Povoa; Ignacio Martin-Loeches
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Prevention of respiratory complications of spinal cord injury: a challenge to "model" spinal cord injury units.

Authors:  John R Bach
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

Review 3.  Ventilator-associated pneumonia: problems with diagnosis and therapy.

Authors:  Jeanine P Wiener-Kronish; Henry Isaiah Dorr
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-09

4.  Diagnosis and Treatment of Ventilator-Associated Infection: Review of the Critical Illness Stress-Induced Immune Suppression Prevention Trial Data.

Authors:  Douglas F Willson; Angela Webster; Sabrina Heidemann; Kathleen L Meert
Journal:  Pediatr Crit Care Med       Date:  2016-04       Impact factor: 3.624

5.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

Review 6.  The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?

Authors:  Lucy B Palmer; Gerald C Smaldone
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2022-01-28       Impact factor: 3.440

7.  Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study.

Authors:  Saad Nseir; Raphaël Favory; Elsa Jozefowicz; Franck Decamps; Florent Dewavrin; Guillaume Brunin; Christophe Di Pompeo; Daniel Mathieu; Alain Durocher
Journal:  Crit Care       Date:  2008-05-02       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.